Drug Interaction Potential of Berberine Hydrochloride When Co-Administered with Tofacitinib and Filgotinib in Rats
Drug Design, Development and Therapy · 2025
DOI: 10.2147/dddt.s491446 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2025. Verfasst von Jinglong Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Shengjing Hospital of China Medical University, Shenyang, Liaoning Province, People's Republic of China. Hauptthemen laut MEDLINE: Pyrimidines, Berberine, Piperidines, Pyrroles. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Shengjing Hospital of China Medical University, Shenyang, Liaoning Province, People's Republic of China.
ORCID-Profile: Jinglong Wang, Guofei Li
Zitieren
APA
Wang, J., Lu, S., Zhang, C., Wang, J., Wu, H., & Li, G. (2025). Drug Interaction Potential of Berberine Hydrochloride When Co-Administered with Tofacitinib and Filgotinib in Rats. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s491446
Vancouver
Wang J, Lu S, Zhang C, Wang J, Wu H, Li G. Drug Interaction Potential of Berberine Hydrochloride When Co-Administered with Tofacitinib and Filgotinib in Rats. Drug Design, Development and Therapy. 2025. doi:10.2147/dddt.s491446
BibTeX
@article{Wang2025,
author = {Wang, Jinglong and Lu, Shijia and Zhang, Chenxiao and Wang, Junjie and Wu, Huiru and Li, Guofei},
title = {Drug Interaction Potential of Berberine Hydrochloride When Co-Administered with Tofacitinib and Filgotinib in Rats},
journal = {Drug Design, Development and Therapy},
year = {2025},
doi = {10.2147/dddt.s491446}
}
EUVIMED